Association of SNPs linked to increased expression of SLC1A1 with schizophrenia

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 159 B, Issue 1, 2012, Pages 30-37

  Horiuchi, Yasue ^a,b   Iida, Syuhei ^a   Koga, Minori ^a,b   Ishiguro, Hiroki ^a,b   Iijima, Yoshimi ^a   Inada, Toshiya ^c   Watanabe, Yuichiro ^d   Someya, Toshiyuki ^d   Ujike, Hiroshi ^e   Iwata, Nakao ^f   Ozaki, Norio ^g   Kunugi, Hiroshi ^h   Tochigi, Mamoru ⁱ   Itokawa, Masanari ^b,j,k   Arai, Makoto ^j   Niizato, Kazuhiro ^k   Iritani, Shuji ^k   Kakita, Akiyoshi ^l   Takahashi, Hitoshi ^l   Nawa, Hiroyuki ^l   Arinami, Tadao ^a,b   more..

^a UNIVERSITY OF TSUKUBA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c SEIWA HOSPITAL   (Japan)

^d NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

^f FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

^j TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^k TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^l NIIGATA UNIVERSITY   (Japan)

more..

Author keywords

Antipsychotics; Glutamate; Postmortem brain; Transporters

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 3;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SCREENING; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BRAIN; DNA COPY NUMBER VARIATIONS; EXCITATORY AMINO ACID TRANSPORTER 3; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMORTEM CHANGES; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA;

EID: 83755163055     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31249     Document Type: Article

References (27)

1. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. 2008. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nat Genet 40(7): 827-834.
2. Amara SG, Sonders MS, Zahniser NR, Povlock SL, Daniels GM. 1998. Molecular physiology and regulation of catecholamine transporters. Adv Pharmacol 42: 164-168.
3. American Psychiatric Association. 2001. Diagnostic and statistical manual of mental health disorders. 4th edition. Washington DC.
4. Andin J, Hallbeck M, Mohammed AH, Marcusson J. 2007. Influence of environmental enrichment on steady-state mRNA levels for EAAC1, AMPA1 and NMDA2A receptor subunits in rat hippocampus. Brain Res 1174: 18-27.
5. Aoyama K, Suh SW, Hamby AM, Liu J, Chan WY, Chen Y, Swanson RA. 2006. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat Neurosci 9(1): 119-126.
6. Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL. 2006. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry 63(7): 769-776.
7. Coyle JT. 2006. Glutamate and schizophrenia: Beyond the dopamine hypothesis. Cell Mol Neurobiol 26(4-6): 365-384.
8. Danbolt NC. 2001. Glutamate uptake. Prog Neurobiol 65(1): 1-105.
9. Deng X, Shibata H, Takeuchi N, Rachi S, Sakai M, Ninomiya H, Iwata N, Ozaki N, Fukumaki Y. 2007. Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia. Am J Med Genet Part B 144B(3): 271-278.
10. Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH Jr, Hanna GL. 2006. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry 63(7): 778-785.
11. Grados M, Wilcox HC. 2007. Genetics of obsessive-compulsive disorder: A research update. Expert Rev Neurother 7(8): 967-980.
12. Kwon JS, Joo YH, Nam HJ, Lim M, Cho EY, Jung MH, Choi JS, Kim B, Kang DH, Oh S, et al. 2009. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms. Arch Gen Psychiatry 66(11): 1233-1241.
13. McCullumsmith RE, Meador-Woodruff JH. 2002. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology 26(3): 368-375.
14. Miyamoto S, Duncan GE, Marx CE, Lieberman JA. 2005. Treatments for schizophrenia: A critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10(1): 79-104.
15. Myers AJ, Gibbs JR, Webster JA, Rohrer K, Zhao A, Marlowe L, Kaleem M, Leung D, Bryden L, Nath P, et al. 2007. A survey of genetic human cortical gene expression. Nat Genet 39(12): 1494-1499.
16. Nudmamud-Thanoi S, Piyabhan P, Harte MK, Cahir M, Reynolds GP. 2007. Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia. J Neural Transm Suppl l: 281-285.
17. Purcell S, Cherny SS, Sham PC. 2003. Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19(1): 149-150.
18. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3): 559-575.
19. Rothstein JD, Martin L, Levey AI, Dykes-Hoberg M, Jin L, Wu D, Nash N, Kuncl RW. 1994. Localization of neuronal and glial glutamate transporters. Neuron 13(3): 713-725.
20. Sarandol A, Kirli S, Akkaya C, Altin A, Demirci M, Sarandol E. 2007. Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: Effects of short term antipsychotic treatment. Prog Neuropsychopharmacol Biol Psychiatry 31(6): 1164-1169.
21. Schmitt A, Zink M, Petroianu G, May B, Braus DF, Henn FA. 2003. Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain. Neurosci Lett 347(2): 81-84.
22. Shigeri Y, Seal RP, Shimamoto K. 2004. Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res Brain Res Rev 45(3): 250-265.
23. Stewart SE, Fagerness JA, Platko J, Smoller JW, Scharf JM, Illmann C, Jenike E, Chabane N, Leboyer M, Delorme R, et al. 2007. Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder. Am J Med Genet Part B 144B(8): 1027-1033.
24. Tuominen HJ, Tiihonen J, Wahlbeck K. 2006. Glutamatergic drugs for schizophrenia. Cochrane Database Syst Rev (2): CD003730.
25. Vacic V, McCarthy S, Malhotra D, Murray F, Chou HH, Peoples A, Makarov V, Yoon S, Bhandari A, Corominas R, et al. 2011. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature 471(7339): 499-503.
26. van Os J, Kapur S. 2009. Schizophrenia. Lancet 374(9690): 635-645.
27. Waxman EA, Baconguis I, Lynch DR, Robinson MB. 2007. N-methyl-D-aspartate receptor-dependent regulation of the glutamate transporter excitatory amino acid carrier 1. J Biol Chem 282(24): 17594-17607.